Quest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch

Dow Jones

2025/04/22

Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow.

Secaucus, N.J.-based Quest $(DGX)$ had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus.

Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. "Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access," he said in prepared remarks.

The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80.

(This is a breaking news story. Check back for updates)

-Ciara Linnane

For more from MarketWatch: http://www.marketwatch.com/newsviewer

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

April 22, 2025 07:01 ET (11:01 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2529743433"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2529743433\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2529743433?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-22 19:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2529743433","market":"nz","top_or_hot":-1,"title":"Quest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. \n</p>\n<p>\n     Secaucus, N.J.-based Quest <a href=\"https://laohu8.com/S/DGX\">$(DGX)$</a> had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus. \n</p>\n<p>\n     Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks. \n</p>\n<p>\n     The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80. \n</p>\n<p>\n     (This is a breaking news story. Check back for updates) \n</p>\n<p>\n     -Ciara Linnane \n</p>\n<p>\n  For more from MarketWatch: http://www.marketwatch.com/newsviewer \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 22, 2025 07:01 ET (11:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuest Diagnostics Earnings Beat After March Rebound In Demand From Slump Early In The Quarter -- MarketWatch\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-04-22 19:01</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. \n</p>\n<p>\n     Secaucus, N.J.-based Quest <a href=\"https://laohu8.com/S/DGX\">$(DGX)$</a> had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus. \n</p>\n<p>\n     Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks. \n</p>\n<p>\n     The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80. \n</p>\n<p>\n     (This is a breaking news story. Check back for updates) \n</p>\n<p>\n     -Ciara Linnane \n</p>\n<p>\n  For more from MarketWatch: http://www.marketwatch.com/newsviewer \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 22, 2025 07:01 ET (11:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DGX","symbol_name":"奎斯特診療","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2529743433","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2529743433","pubTimestamp":1745319660,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow.Secaucus, N.J.-based Quest  had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus.Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks.The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80.This content was created by MarketWatch, which is opera","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"DGX":"奎斯特诊疗"},"translate_title":"Quest Diagnostics的盈利在3月份需求从季度初的低迷中反弹后超出预期——MarketWatch","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":1},"content_text":"Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company  posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. \n\n\n     Secaucus, N.J.-based Quest $(DGX)$ had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus. \n\n\n     Chief Executive Jim Davis said growth rebounded in March after a weather-related slump early in the quarter. \"Our growth was due to contributions from acquisitions and large enterprise accounts, demand for our advanced diagnostics portfolio, and expanded health plan access,\" he said in prepared remarks. \n\n\n     The company backed its revenue guidance for 2025 of $10.7 billion to $10.85 billion. It raised its EPS guidance to $8.62 to $8.87 from $8.34 to $8.59 previously, but stuck with adjusted EPs guidance of $9.55 to $9.80. \n\n\n     (This is a breaking news story. Check back for updates) \n\n\n     -Ciara Linnane \n\n\n  For more from MarketWatch: http://www.marketwatch.com/newsviewer \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 22, 2025 07:01 ET (11:01 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}